Alkem Lab Introduces Pertuzumab Biosimilar ‘Pertuza’ in India

💊

has launched Pertuza, a biosimilar of pertuzumab, for the treatment of HER2-positive breast cancer in India. This marks a significant expansion of the company’s oncology portfolio, strengthening its presence in the domestic pharmaceutical market.